Gencor Releases Third Quarter Fiscal 2016 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Gencor Releases Third Quarter Fiscal 2016 Results

ORLANDO, Fla., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (Nasdaq: GENC ) announced today net revenue for the quarter ended June 30, 2016 increased 81.6% to $19.9 million from $10.9 million for the quarter ended June 30, 2015.  Gross margin increased to 25.9% for the quarter ended June 30, 2016 from 21.9% for the quarter ended June 30, 2015.  Selling, general and administrative (“SG&A”) expenses increased 16.2% to $1,979,000 for the quarter ended June 30, 2016, from $1,703,000 for the quarter ended June 30, 2015. Increased sales expenses due to higher sales volume and trade show expenses, contributed to the increased SG&A expenses. Operating income for the quarter ended June 30, 2016 was $2,793,000 compared to $345,000 for the quarter ended June 30, 2015.  Operating margin was 14.1% for the quarter ended June 30, 2016 compared to 3.2% for the quarter ended June 30, 2015.

The Company had non-operating income of $563,000 for the quarter ended June 30, 2016 compared to non-operating income of $77,000 for the quarter ended June 30, 2015.  Net income was $2.1 million, or $0.22 per basic and diluted share, for the quarter ended June 30, 2016, compared to $0.3 million, or $0.03 per basic and diluted share, for the quarter ended June 30, 2015.

For the nine months ended June 30, 2016, the Company had net revenue of $55.2 million and net income of $5.3 million ($0.56 per basic share and $0.55 per diluted share) versus net revenue of $31.0 million and net income of $0.4 million ($0.04 per basic and diluted share) for the nine months ended June 30, 2015.

At June 30, 2016, the Company had $96.5 million in cash and marketable securities compared to $95.5 million at September 30, 2015.  Net working capital was $112.2 million at June 30, 2016.  The Company has no short or long term debt.

E.J. Elliott, Gencor’s CEO & Chairman, commented, “I am pleased to report another quarter of significant growth for Gencor.   Revenues increased over 80% in the third quarter and 78% for the first nine months of fiscal 2016.  Demand for Gencor’s equipment continues to be robust.  Gross margins remain solid even though pricing is very competitive. SG&A as a percentage of revenue has dropped notably as a result of maintaining tight controls on general and administrative expenses.  We have increased sales efforts to capitalize on the greatly improved outlook for the domestic highway construction industry.

After the quarter ended, we shipped asphalt plants which were subsequently billed and collected in July.  Revenue from the sale of these plants was recognized during the third quarter of fiscal 2016.

A substantial portion of the $21 million current backlog will be recognized in the fourth quarter.  In the fourth quarter of fiscal 2015 we reported revenues of $8.2 million.  Thus, we are optimistic that the fourth quarter of 2016 will be another quarter of solid growth.  Furthermore, we have secured favorable raw material pricing contracts for the fourth quarter and going into fiscal 2017.  Therefore, we expect fourth quarter gross margins to be consistent with the most recent quarters.

Quoting activity for fiscal 2017 deliveries looks encouraging.  We continue to ramp up our operations to meet the increased demand for our equipment.”

Gencor Industries, Inc. is a diversified heavy machinery manufacturer of equipment used in the production of highway construction materials, synthetic fuels, and environmental control machinery and equipment used in a variety of industrial applications. 

Caution Concerning Forward Looking Statements - This press release and our other communications and statements may contain “forward-looking statements,” including statements about our beliefs, plans, objectives, goals, expectations, estimates, projections and intentions.  These statements are subject to significant risks and uncertainties and are subject to change based on various factors, many of which are beyond our control.  The words “may,” “could,” “should,” “would,” “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “target,” “goal,” and similar expressions are intended to identify forward-looking statements.  All forward-looking statements, by their nature, are subject to risks and uncertainties.  Our actual future results may differ materially from those set forth in our forward-looking statements.  For information concerning these factors and related matters, see our Annual Report on Form 10-K for the year ended September 30, 2015; (a) “Risk Factors” in Part I, Item 1A and (b)  “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7.  However, other factors besides those referenced could adversely affect our results, and you should not consider any such list of factors to be a complete set of all potential risks or uncertainties.  Any forward-looking statements made by us herein speak as of the date of this press release.  We do not undertake to update any forward-looking statement, except as required by law.

Contact: Eric Mellen, Chief Financial Officer 407-290-6000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 115

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 194

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 94

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 279

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 151

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 88

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

AXIS Capital Leadership Changes Enhance Global Operations

Updated Category News Views 115

AXIS Capital Leadership Appointments for Irish Entities AXIS Capital Holdings Limited (NYSE: AXS) has taken significant steps to enhance its operational leadership. Recently, the company announced key leadership appointments for its Irish legal entities, AXIS Re SE ("ARe") and AXIS Specialty Europe SE ("ASE"). Both entities are based in Ireland and are regulated by the...

Continue Reading
AI Transformation and Market Growth in Office Supplies B2B Sector

Updated Category News Views 202

The global office stationery and supplies B2B market experienced a significant transformation driven by artificial intelligence and an uptick in business expansions. Back in 2024, the market was poised to grow by USD 20.5 billion from then to 2028, translating to a compound annual growth rate (CAGR) of 1.96%. The rising demand for environmentally friendly and recyclable...

Continue Reading
NewLake Capital Strengthens Board with Dina Rollman's Addition

Updated Category News Views 293

NewLake Capital Partners Welcomes Dina Rollman NewLake Capital Partners, Inc. (OTCQX: NLCP), a prominent provider of real estate capital to state-licensed cannabis operators, is excited to announce the recent appointment of Dina Rollman to its Board of Directors. This strategic move aims to bolster the company’s leadership as it continues to thrive in the evolving...

Continue Reading
Nasdaq Reports Surge in IPO Activity for 2025 to Date

Updated Category News Views 1069

Record Activity in Nasdaq's IPO Sphere for 2025 As the trading world gained momentum in 2025, Nasdaq showcased remarkable activity, welcoming 142 initial public offerings (IPOs) during the first half of the year. This impressive figure translated into a substantial capital raise of $19.2 billion, marking a significant resurgence in the IPO arena. Robust Listings and...

Continue Reading
Introducing ecoVerificado.com: A New Standard for Baby Diapers

Updated Category News Views 92

Revolutionizing Eco-Friendly Baby Diapers In an exciting development for the baby care industry, GreenCore Solutions Corp. has launched ecoVerificado.com, creating a brand new standard for sustainable private-label baby diapers. This initiative is a game changer for manufacturers in Latin America, enabling the production of premium ecological diapers without compromising...

Continue Reading